Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1.

Marini A, Rossi O, Aruta MG, Micoli F, Rondini S, Guadagnuolo S, Delany I, Henderson IR, Cunningham AF, Saul A, MacLennan CA, Koeberling O.

PLoS One. 2017 Jul 25;12(7):e0181508. doi: 10.1371/journal.pone.0181508. eCollection 2017.

2.

Neisseria cinerea expresses a functional factor H binding protein which is recognised by immune responses elicited by meningococcal vaccines.

Lavender H, Poncin K, Tang CM.

Infect Immun. 2017 Jul 24. pii: IAI.00305-17. doi: 10.1128/IAI.00305-17. [Epub ahead of print]

3.

Biological Functions of the Secretome of Neisseria meningitidis.

Tommassen J, Arenas J.

Front Cell Infect Microbiol. 2017 Jun 16;7:256. doi: 10.3389/fcimb.2017.00256. eCollection 2017. Review.

4.

The role of anti-NHba antibody in bactericidal activity elicited by the meningococcal serogroup B vaccine, MenB-4C.

Partridge E, Lujan E, Giuntini S, Vu DM, Granoff DM.

Vaccine. 2017 Jul 24;35(33):4236-4244. doi: 10.1016/j.vaccine.2017.06.020. Epub 2017 Jun 23.

PMID:
28651840
5.

Identification of a Large Family of Slam-Dependent Surface Lipoproteins in Gram-Negative Bacteria.

Hooda Y, Lai CCL, Moraes TF.

Front Cell Infect Microbiol. 2017 May 31;7:207. doi: 10.3389/fcimb.2017.00207. eCollection 2017.

6.

The Hfq regulon of Neisseria meningitidis.

Huis In 't Veld RAG, Kramer G, van der Ende A, Speijer D, Pannekoek Y.

FEBS Open Bio. 2017 Apr 25;7(6):777-788. doi: 10.1002/2211-5463.12218. eCollection 2017 Jun.

7.

Gonococcal lipooligosaccharide sialylation: virulence factor and target for novel immunotherapeutics.

Ram S, Shaughnessy J, de Oliveira RB, Lewis LA, Gulati S, Rice PA.

Pathog Dis. 2017 Jun 1;75(4). doi: 10.1093/femspd/ftx049.

PMID:
28460033
8.

Multicomponent meningococcal B vaccination (4CMenB) of adolescents and college students in the United States.

Banzhoff A.

Ther Adv Vaccines. 2017 Feb;5(1):3-14. doi: 10.1177/2051013616681365. Epub 2017 Jan 6. Review.

9.

The Rickettsia conorii Adr1 Interacts with the C-Terminus of Human Vitronectin in a Salt-Sensitive Manner.

Fish AI, Riley SP, Singh B, Riesbeck K, Martinez JJ.

Front Cell Infect Microbiol. 2017 Mar 1;7:61. doi: 10.3389/fcimb.2017.00061. eCollection 2017.

10.

Staphylococcal protein Ecb impairs complement receptor-1 mediated recognition of opsonized bacteria.

Amdahl H, Haapasalo K, Tan L, Meri T, Kuusela PI, van Strijp JA, Rooijakkers S, Jokiranta TS.

PLoS One. 2017 Mar 8;12(3):e0172675. doi: 10.1371/journal.pone.0172675. eCollection 2017.

11.

A versatile assay to determine bacterial and host factors contributing to opsonophagocytotic killing in hirudin-anticoagulated whole blood.

van der Maten E, de Jonge MI, de Groot R, van der Flier M, Langereis JD.

Sci Rep. 2017 Feb 8;7:42137. doi: 10.1038/srep42137.

12.

A defined syphilis vaccine candidate inhibits dissemination of Treponema pallidum subspecies pallidum.

Lithgow KV, Hof R, Wetherell C, Phillips D, Houston S, Cameron CE.

Nat Commun. 2017 Feb 1;8:14273. doi: 10.1038/ncomms14273.

13.

The role of apolipoprotein N-acyl transferase, Lnt, in the lipidation of factor H binding protein of Neisseria meningitidis strain MC58 and its potential as a drug target.

da Silva RAG, Churchward CP, Karlyshev AV, Eleftheriadou O, Snabaitis AK, Longman MR, Ryan A, Griffin R.

Br J Pharmacol. 2017 Jul;174(14):2247-2260. doi: 10.1111/bph.13660. Epub 2016 Dec 21.

PMID:
27784136
14.

Enhanced protective antibody to a mutant meningococcal factor H-binding protein with low-factor H binding.

Granoff DM, Giuntini S, Gowans FA, Lujan E, Sharkey K, Beernink PT.

JCI Insight. 2016 Sep 8;1(14):e88907. doi: 10.1172/jci.insight.88907.

15.

Human IgG1, IgG3, and IgG3 Hinge-Truncated Mutants Show Different Protection Capabilities against Meningococci Depending on the Target Antigen and Epitope Specificity.

Giuntini S, Granoff DM, Beernink PT, Ihle O, Bratlie D, Michaelsen TE.

Clin Vaccine Immunol. 2016 Aug 5;23(8):698-706. doi: 10.1128/CVI.00193-16. Print 2016 Aug.

16.

Utilizing complement evasion strategies to design complement-based antibacterial immunotherapeutics: Lessons from the pathogenic Neisseriae.

Ram S, Shaughnessy J, DeOliveira RB, Lewis LA, Gulati S, Rice PA.

Immunobiology. 2016 Oct;221(10):1110-23. doi: 10.1016/j.imbio.2016.05.016. Epub 2016 Jun 1. Review.

17.

Cloning, expression and purification of the factor H binding protein and its interaction with factor H.

Yarian F, Bandehpour M, Seyed N, Kazemi B.

Iran J Microbiol. 2016 Feb;8(1):29-35.

18.

Meningococcal Factor H Binding Protein Vaccine Antigens with Increased Thermal Stability and Decreased Binding of Human Factor H.

Rossi R, Konar M, Beernink PT.

Infect Immun. 2016 May 24;84(6):1735-42. doi: 10.1128/IAI.01491-15. Print 2016 Jun.

19.

Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined.

Biagini M, Spinsanti M, De Angelis G, Tomei S, Ferlenghi I, Scarselli M, Rigat F, Messuti N, Biolchi A, Muzzi A, Anderloni G, Brunelli B, Cartocci E, Buricchi F, Tani C, Stella M, Moschioni M, Del Tordello E, Colaprico A, Savino S, Giuliani MM, Delany I, Pizza M, Costantino P, Norais N, Rappuoli R, Masignani V.

Proc Natl Acad Sci U S A. 2016 Mar 8;113(10):2714-9. doi: 10.1073/pnas.1521142113. Epub 2016 Feb 17.

20.

Impact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles.

Daniels-Treffandier H, de Nie K, Marsay L, Dold C, Sadarangani M, Reyes-Sandoval A, Langford PR, Wyllie D, Hill F, Pollard AJ, Rollier CS.

PLoS One. 2016 Feb 12;11(2):e0148840. doi: 10.1371/journal.pone.0148840. eCollection 2016.

Supplemental Content

Support Center